EyeGate Pharma Announces Positive Results in Punctate Epitheliopathy Study
WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today announced top-line data from its study […]
National Vision Holdings, Inc. Reports Third Quarter 2018 Financial Results
Net revenue increased 11.9% to $387.4 million Comparable store sales growth of 7.0%; Adjusted comparable store sales growth of 6.8% […]
EyeGate Pharma Announces Positive Results in Second PRK Study
Data confirms results from earlier study WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) today […]
Superconductor Technologies Reports Third Quarter 2018 Results
AUSTIN, Texas, Nov. 13, 2018 (GLOBE NEWSWIRE) — Superconductor Technologies Inc. (STI) (Nasdaq: SCON) reported financial results for the three […]
InvaGen (a Cipla subsidiary) Announces Acquisition Agreement with Avenue Therapeutics for Specialty Hospital Business in the U.S.
Upon first stage closing, InvaGen Pharmaceuticals Inc., a Cipla subsidiary (“InvaGen”), to acquire shares representing a 33.3% stake in Avenue […]
Jounce Therapeutics Reports Third Quarter 2018 Financial Results
– Dose escalation cohorts of JTX-2011 Phase 1/2 ICONIC trial, in combination with ipilimumab and in combination with pembrolizumab, on […]
Eyenovia Reports Third Quarter 2018 Financial Results
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) — Eyenovia, Inc. (NASDAQ: EYEN), a biopharmaceutical company developing a pipeline of ophthalmology […]
Surface Oncology Reports Financial Results and Corporate Highlights for Third Quarter 2018
CAMBRIDGE, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the […]
TSX News -
Eastmain Drills 2.35 g/t Gold over 87 metres and 1.46 g/t Gold over 78.5 metres on Newly Discovered Percival Prospect at the Clearwater Property
TORONTO, Nov. 13, 2018 (GLOBE NEWSWIRE) — Eastmain Resources Inc. (“Eastmain” or the “Company” – TSX:ER, OTCQX:EANRF) announces the discovery […]
Great Elm Capital Corp. Announces Third Quarter 2018 Financial Results; Net Investment Income of $0.25 Per Share; Board Sets First Quarter 2019 Distribution of $0.25 Per Share ($0.083 Per Share Per Month)
WALTHAM, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE) — Great Elm Capital Corp. (“we,” “us,” “our” or “GECC”), (NASDAQ: GECC), today […]
